Development and validation of novel autophagy biomarkers for malignant melanoma
Cutaneous melanoma is an increasing health problem with an incidence that has steadily increased internationally in the last fifty years. When detected early, excision of the primary tumour is usually curative, however, metastatic disease remains extremely resistant to therapy and as yet, there is s...
Main Author: | Ellis, Robert Alexander |
---|---|
Published: |
University of Newcastle Upon Tyne
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.627724 |
Similar Items
-
Purinergic signalling in malignant melanoma
by: White, Nicholas
Published: (2005) -
Examination of interferon alpha transcription defects exhibited by malignant melanoma
by: Price, Karen Leigh
Published: (2005) -
Improving outcome in melanoma by early detection and identification of novel prognostic markers
by: Pacifico, Marc Dominic
Published: (2005) -
Development of specific antibody fragments for the detection and treatment of melanoma
by: Odili, Joy Ifeyinewa
Published: (2006) -
Prognostic factors in very thin melanoma
by: Fearfield, Louise Anne
Published: (2003)